These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37804998)

  • 1. Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study.
    Tratnjek L; Simić L; Vukelić K; Knežević Z; Kreft ME
    Eur J Pharm Biopharm; 2023 Nov; 192():136-146. PubMed ID: 37804998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study investigating Ectoin
    Werkhäuser N; Bilstein A; Mahlstedt K; Sonnemann U
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1371-1381. PubMed ID: 34089097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
    Castellano F; Mautone G
    Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal mucociliary transport: new evidence for a key role of ciliary beat frequency.
    Boek WM; Graamans K; Natzijl H; van Rijk PP; Huizing EH
    Laryngoscope; 2002 Mar; 112(3):570-3. PubMed ID: 12148873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T; Scheffler R
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold.
    Hagen M; Clark K; Kalita P; Serra G; Sanchez E; Varbiro G; Albasser MM
    Ther Adv Respir Dis; 2024; 18():17534666241228927. PubMed ID: 38372128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-assisted video measurement of inhibition of ciliary beat frequency of human nasal epithelium in vitro by xylometazoline.
    Curtis LN; Carson JL
    J Pharmacol Toxicol Methods; 1992 Aug; 28(1):1-7. PubMed ID: 1356521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nasal decongestant effect of xylometazoline in the common cold.
    Eccles R; Eriksson M; Garreffa S; Chen SC
    Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection.
    Eccles R; Pedersen A; Regberg D; Tulento H; Borum P; Stjärne P
    Am J Rhinol; 2007; 21(1):40-5. PubMed ID: 17283559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Ciliotoxicity and Cytotoxicity Testing of Repeated Chronic Exposure to Topical Nasal Formulations for Safety Studies.
    Tratnjek L; Sibinovska N; Kristan K; Kreft ME
    Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of protective and therapeutic effects of dexpanthenol on nasal decongestants and preservatives: results of cytotoxic studies in vitro.
    Klöcker N; Rudolph P; Verse T
    Am J Rhinol; 2004; 18(5):315-20. PubMed ID: 15586804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciliary beat frequency of in vitro human nasal epithelium measured with the simple high-speed microscopy is applicable for safety studies of nasal drug formulations.
    Tratnjek L; Kreft M; Kristan K; Kreft ME
    Toxicol In Vitro; 2020 Aug; 66():104865. PubMed ID: 32311434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature.
    Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of the use of xylometazoline nasal spray in young children undergoing lacrimal surgery: an observational study.
    Joganathan V; Beigi B
    Eur J Ophthalmol; 2018 May; 28(3):279-281. PubMed ID: 29077183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective effect of dexpanthenol in nasal sprays. First results of cytotoxic and ciliary-toxic studies in vitro].
    Klöcker N; Verse T; Rudolph P
    Laryngorhinootologie; 2003 Mar; 82(3):177-82. PubMed ID: 12673516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro studies of the effect of vasoconstrictor nose drops on ciliary epithelium of human nasal mucosa].
    Hofmann T; Wolf G; Koidl B
    Laryngorhinootologie; 1995 Sep; 74(9):564-7. PubMed ID: 7495440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis.
    Graf C; Bernkop-Schnürch A; Egyed A; Koller C; Prieschl-Grassauer E; Morokutti-Kurz M
    Int J Gen Med; 2018; 11():275-283. PubMed ID: 30013382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays.
    Mösges R; Shah-Hosseini K; Hucke HP; Joisten MJ
    Adv Ther; 2017 Aug; 34(8):1850-1858. PubMed ID: 28695477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal decongestants in monotherapy for the common cold.
    Deckx L; De Sutter AI; Guo L; Mir NA; van Driel ML
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009612. PubMed ID: 27748955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.